Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 181 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

Chronic Myeloid Leukemia (CML) Phase2 France

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Familial Hypercholesterolemia - Homozygous Phase3 Austria
China
Germany
Greece
Malaysia
Netherlands
South Africa
Taiwan
Turkey (Türkiye)
United Kingdom
United States
View all

A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence

Breast Neoplasms Austria
Germany

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

Dengue Phase2 Brazil
Colombia
India
Malaysia
Mexico
Singapore
Vietnam
View all

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Prostate Cancer Phase2, Phase3 Australia
Brazil
China
Hong Kong
Israel
Japan
Malaysia
Mexico
Singapore
South Korea
Switzerland
Taiwan
United States
View all

Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study

Relapsing Multiple Sclerosis (RMS) Greece

Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)

Pediatric Chronic Heart Failure Japan

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Familial Hypercholesterolemia - Heterozygous Phase3 Argentina
Austria
Belgium
Brazil
China
Czechia
France
Germany
Greece
Hong Kong
Hungary
Israel
Italy
Malaysia
Netherlands
Poland
Portugal
South Africa
Spain
Taiwan
Turkey (Türkiye)
United Kingdom
United States
View all

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

Relapsing Remitting Multiple Sclerosis (RRMS) Phase4 Canada

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

Healthy Volunteers, Pulmonary Arterial Hypertension Phase1, Phase2 Argentina
Australia
Belgium
Brazil
Czechia
France
Germany
Greece
Italy
Latvia
Mexico
Poland
Portugal
Romania
Serbia
Spain
United Kingdom
United States
View all